scholarly journals Cardiopulmonary Arrest After COVID-19 Vaccination: A Case Report

Cureus ◽  
2022 ◽  
Author(s):  
Waleed Sadiq ◽  
Madeeha Subhan Waleed ◽  
Phyllis Suen ◽  
Michel N Chalhoub
Keyword(s):  
Case Report ◽  
Cardiopulmonary Arrest

scholarly journals Cardiopulmonary arrest in pregnancy with schizophrenia: a case report

2014 ◽  
Vol 7 (1) ◽  
pp. 821
Author(s):  
Takako Kudo ◽  
Akimune Kaga ◽  
Kozo Akagi ◽  
Hideki Iwahashi ◽  
Hiromitsu Makino ◽  
...  
Keyword(s):  
Case Report ◽  
Cardiopulmonary Arrest ◽  
In Pregnancy

Myasthenia Gravis Associated With Programmed Death-1 (PD-1) Receptor Inhibitor Pembrolizumab: A 40-day Case Report

2020 ◽  
pp. 089719002097075
Author(s):  
Aidan S. Ziobro ◽  
Reid L. LaPlante ◽  
Shayna R. DeMari ◽  
Larissa M. Clark ◽  
David J. Kingsley ◽  
...  
Keyword(s):  
Cell Death ◽  
Case Report ◽  
Programmed Cell Death ◽  
Adverse Events ◽  
Myasthenia Gravis ◽  
Cardiopulmonary Arrest ◽  
Palliative Therapy ◽  
Treatment Modalities ◽  
Duration Of Treatment ◽  
Serious Adverse Events

Purpose: This case report describes myasthenia gravis-like symptoms after treatment with a programmed cell death 1 inhibitor, pembrolizumab, the treatment modalities utilized, and associated patient outcomes. Summary: A 76-year old male treated with pembrolizumab for palliative therapy for metastatic melanoma presented with increasing weakness, neck pain, diplopia in the left eye, abducens palsy, periorbital edema, and decreased appetite. The patient was diagnosed with acetylcholine receptor antibody (AChR) negative myasthenia gravis. The patient was started on prednisone 1 mg/kg/day, followed by pyridostigmine 60 mg by mouth 3 times a day, and IVIg for 5 days. Due to minor improvements in myasthenia gravis symptoms, 5 cycles of plasmapheresis were ordered. The patient was successfully treated for aspiration pneumonia after cardiopulmonary arrest. On day 28, the patient was diagnosed with ventilator associated pneumonia and received appropriate therapy. Due to ICU agitation and delirium, VAP, and long duration of treatment, the patient requested withdrawal of care and passed. Conclusion: Programmed cell death inhibitors, such as pembrolizumab, can provide great benefit to patients but can also be associated with rare but serious adverse events. With new reports of MG after use, providers should continually weigh the benefits versus harm in using these products and monitor patients closely for such adverse events.

Survival of a subarachnoid hemorrhage patient who presented with prehospital cardiopulmonary arrest: case report and review of the literature

Resuscitation ◽  
2001 ◽  
Vol 51 (2) ◽  
pp. 207-211 ◽  
Author(s):  
Joji Inamasu ◽  
Ryoichi Saito ◽  
Yoshiki Nakamura ◽  
Kiyoshi Ichikizaki ◽  
Sadao Suga ◽  
...  
Keyword(s):  
Case Report ◽  
Subarachnoid Hemorrhage ◽  
Cardiopulmonary Arrest ◽  
Review Of The Literature

scholarly journals Bedside colectomy for non-occlusive mesenteric ischemia with cardiopulmonary arrest: a case report

2020 ◽  
Vol 27 (6) ◽  
pp. 477-478
Author(s):  
Yoshifumi Katsumata ◽  
Tomoaki Yatabe ◽  
Hiroyuki Kitagawa ◽  
Bun Aoyama ◽  
Hiroki Tateiwa ◽  
...  
Keyword(s):  
Case Report ◽  
Mesenteric Ischemia ◽  
Cardiopulmonary Arrest ◽  
Occlusive Mesenteric Ischemia

scholarly journals Cardiopulmonary arrest caused by acute abdominal aortic thrombosis: a case report

2009 ◽  
Vol 2009 (apr23 1) ◽  
pp. bcr0920080947-bcr0920080947 ◽  
Author(s):  
Y. Matsuoka ◽  
M. Hashizume
Keyword(s):  
Case Report ◽  
Cardiopulmonary Arrest ◽  
Aortic Thrombosis ◽  
Abdominal Aortic
Sign in / Sign up

Export Citation Format

Share Document